Technology
Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck
For developers, the operating assumption has been one engineer, one agent — the model Claude Code and similar tools.
AI Summary
Stanford University's virtual biotech platform is utilizing a large-scale AI system, comprising 37,000 agents, to design and test potential drugs. This system's capabilities have been validated by an independent confirmation from Merck, a pharmaceutical company, which has verified one of the platform's drug designs. The success of this platform highlights the potential of large-scale AI systems to collaborate and produce meaningful results, challenging the conventional assumption that a single, more capable agent is the key to innovation.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Technology
Continue reading recent Technology coverage
- Microsoft puts Brad Smith in charge of communicationsContinue reading
- Ray-Ban Meta Gen 3 vs. Ray-Ban Meta Gen 2: How these AI glasses compareContinue reading
- Nintendo wins $4.5 million from lawsuit over pirated Switch gamesContinue reading
- Nicolas Cage is anything but subtle in the Madden trailerContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow